489 related articles for article (PubMed ID: 11320344)
1. National serologic survey of measles immunity among persons 6 years of age or older, 1988-1994.
Hutchins SS; Redd SC; Schrag S; Kruszon-Moran D; Wooten K; McQuillan GM; Bellini W; Meyer PA; Hadler S
MedGenMed; 2001 Jan; ():E5. PubMed ID: 11320344
[TBL] [Abstract][Full Text] [Related]
2. Population immunity to measles in the United States, 1999.
Hutchins SS; Bellini WJ; Coronado V; Jiles R; Wooten K; Deladisma A
J Infect Dis; 2004 May; 189 Suppl 1():S91-7. PubMed ID: 15106096
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of measles antibody in the US population, 1999-2004.
McQuillan GM; Kruszon-Moran D; Hyde TB; Forghani B; Bellini W; Dayan GH
J Infect Dis; 2007 Nov; 196(10):1459-64. PubMed ID: 18008224
[TBL] [Abstract][Full Text] [Related]
4. Changing levels of measles antibody titers in women and children in the United States: impact on response to vaccination. Kaiser Permanente Measles Vaccine Trial Team.
Markowitz LE; Albrecht P; Rhodes P; Demonteverde R; Swint E; Maes EF; Powell C; Patriarca PA
Pediatrics; 1996 Jan; 97(1):53-8. PubMed ID: 8545224
[TBL] [Abstract][Full Text] [Related]
5. Measles virus haemagglutination-inhibition antibodies among pregnant and non-pregnant women in the vaccine era in Harare, Zimbabwe.
Obi CL; Tswana SA; Moyo SR; Berejena C
Cent Afr J Med; 1996 May; 42(5):135-8. PubMed ID: 8771931
[TBL] [Abstract][Full Text] [Related]
6. A population-based serologic survey of immunity to tetanus in the United States.
Gergen PJ; McQuillan GM; Kiely M; Ezzati-Rice TM; Sutter RW; Virella G
N Engl J Med; 1995 Mar; 332(12):761-6. PubMed ID: 7862178
[TBL] [Abstract][Full Text] [Related]
7. Humoral and cellular immune response after measles vaccination in Taiwan.
Huang CL; Yang YH; Wang LC; Lin YT; Tsai YY; Chiang BL
J Microbiol Immunol Infect; 2005 Jun; 38(3):169-75. PubMed ID: 15986066
[TBL] [Abstract][Full Text] [Related]
8. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan.
Chiu HH; Lee CY; Chih TW; Lee PI; Chang LY; Lin YJ; Hsu CM; Huang LM
J Med Virol; 1997 Jan; 51(1):32-5. PubMed ID: 8986946
[TBL] [Abstract][Full Text] [Related]
9. Rubella seropositivity in the United States, 1988-1994.
Dykewicz CA; Kruszon-Moran D; McQuillan GM; Williams WW; Van Loon FP; Cossen C; Forghani B; Hadler SC
Clin Infect Dis; 2001 Oct; 33(8):1279-86. PubMed ID: 11565065
[TBL] [Abstract][Full Text] [Related]
10. Residual susceptibility to measles among young adults in Victoria, Australia following a national targeted measles-mumps-rubella vaccination campaign.
Kelly HA; Gidding HF; Karapanagiotidis T; Leydon JA; Riddell MA
BMC Public Health; 2007 Jun; 7():99. PubMed ID: 17555601
[TBL] [Abstract][Full Text] [Related]
11. [Measles and mumps antibody concentrations in newborns and their mothers--follow up first year of life].
Hohendahl J; Peters N; Hüttermann U; Rieger C
Klin Padiatr; 2006; 218(4):213-20. PubMed ID: 16819702
[TBL] [Abstract][Full Text] [Related]
12. Persistence of measles antibodies after 2 doses of measles vaccine in a postelimination environment.
LeBaron CW; Beeler J; Sullivan BJ; Forghani B; Bi D; Beck C; Audet S; Gargiullo P
Arch Pediatr Adolesc Med; 2007 Mar; 161(3):294-301. PubMed ID: 17339511
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of hepatitis B virus infection in the United States in the era of vaccination.
Wasley A; Kruszon-Moran D; Kuhnert W; Simard EP; Finelli L; McQuillan G; Bell B
J Infect Dis; 2010 Jul; 202(2):192-201. PubMed ID: 20533878
[TBL] [Abstract][Full Text] [Related]
14. Varicella in Americans from NHANES III: implications for control through routine immunization.
Kilgore PE; Kruszon-Moran D; Seward JF; Jumaan A; Van Loon FP; Forghani B; McQuillan GM; Wharton M; Fehrs LJ; Cossen CK; Hadler SC
J Med Virol; 2003; 70 Suppl 1():S111-8. PubMed ID: 12627498
[TBL] [Abstract][Full Text] [Related]
15. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994.
Staras SA; Dollard SC; Radford KW; Flanders WD; Pass RF; Cannon MJ
Clin Infect Dis; 2006 Nov; 43(9):1143-51. PubMed ID: 17029132
[TBL] [Abstract][Full Text] [Related]
17. Sero-epidemiology of measles-specific IgG antibodies and predictive factors for low or missing titres in a German population-based cross-sectional study in children and adolescents (KiGGS).
Poethko-Müller C; Mankertz A
Vaccine; 2011 Oct; 29(45):7949-59. PubMed ID: 21872633
[TBL] [Abstract][Full Text] [Related]
18. [Measles: immunity and vaccination status in Greater Frankfurt on the Main].
Friedrichs I; Doerr HW; Allwinn R
Dtsch Med Wochenschr; 2012 Jan; 137(4):121-5. PubMed ID: 22259164
[TBL] [Abstract][Full Text] [Related]
19. Predicting and comparing long-term measles antibody profiles of different immunization policies.
Lee MS; Nokes DJ
Bull World Health Organ; 2001; 79(7):615-24. PubMed ID: 11477964
[TBL] [Abstract][Full Text] [Related]
20. [Presence of IgG class antibodies anti-measles virus in sera of subjects in different age].
Cześcik A; Dunal M; Trzcińska A; Siennicka J
Med Dosw Mikrobiol; 2012; 64(1):73-8. PubMed ID: 22808732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
